APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Swine Reproductive and Respiratory Syndrome Vaccine

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Selected research

Industry Growth & Trends

Global Swine Reproductive and Respiratory Syndrome Vaccine Industry Growth and Trends Forecast to 2032

Report ID 174039020130 December 2025113 pages

Choose your research edition.

Industry ResearchSwine Reproductive and Respiratory Syndrome Vaccine Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Reproductive and Respiratory Syndrome Vaccine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Swine Reproductive and Respiratory Syndrome Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Reproductive and Respiratory Syndrome Vaccine Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Reproductive and Respiratory Syndrome Vaccine Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Boehringer ingelheim is the company with the largest market share, about 25 percent.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Swine Reproductive and Respiratory Syndrome Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Swine Reproductive and Respiratory Syndrome Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Swine Reproductive and Respiratory Syndrome Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Swine Reproductive and Respiratory Syndrome Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Swine Reproductive and Respiratory Syndrome Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Swine Reproductive and Respiratory Syndrome Vaccine Market by Company

ASCENT CORPORATION

Boehringer-Ingelheim

MSD Animal Health

SPAH

Ceva

Chengdu TECH-BANK Biological Products Co,.Ltd

ringpu

QILU ANIMAL HEALTH PRODUCTS CO.,LTD

DAHUANONG

CAVAC

Komipharm

Agrovet

Bioveta

JINYU BIO-TECNOLOGY CO.,LTD

Phibro Animal Health

ANHUI TIANKANG(GROUP)SHRES O., LTD

Zoetis

WINSUN BIO

PULIKE BIOLOGICAL ENGINERING,INC.

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Type

Active Vaccine

Inactivated Vaccines

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Application

Government Tender

Market Sales

Swine Reproductive and Respiratory Syndrome Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Reproductive and Respiratory Syndrome Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Reproductive and Respiratory Syndrome Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Reproductive and Respiratory Syndrome Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Swine Reproductive and Respiratory Syndrome Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Swine Reproductive and Respiratory Syndrome Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Active Vaccine Table 2. Major Company of Inactivated Vaccines Table 3. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2021-2026) & (USD/Unit) Table 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2027-2032) & (USD/Unit) Table 14. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends Table 25. Swine Reproductive and Respiratory Syndrome Vaccine Industry Drivers Table 26. Swine Reproductive and Respiratory Syndrome Vaccine Industry Opportunities and Challenges Table 27. Swine Reproductive and Respiratory Syndrome Vaccine Industry Restraints Table 28. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Company (2021-2026) Table 32. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Swine Reproductive and Respiratory Syndrome Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Swine Reproductive and Respiratory Syndrome Vaccine Major Company Production Sites and Headquarters Table 35. Global Swine Reproductive and Respiratory Syndrome Vaccine Company, Product Type & Application Table 36. Global Swine Reproductive and Respiratory Syndrome Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Swine Reproductive and Respiratory Syndrome Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2021-2026) & (USD/Unit) Table 56. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2027-2032) & (USD/Unit) Table 61. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. ASCENT CORPORATION Company Information Table 72. ASCENT CORPORATION Business Overview Table 73. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 75. ASCENT CORPORATION Recent Development Table 76. Boehringer-Ingelheim Company Information Table 77. Boehringer-Ingelheim Business Overview Table 78. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 80. Boehringer-Ingelheim Recent Development Table 81. MSD Animal Health Company Information Table 82. MSD Animal Health Business Overview Table 83. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 85. MSD Animal Health Recent Development Table 86. SPAH Company Information Table 87. SPAH Business Overview Table 88. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 90. SPAH Recent Development Table 91. Ceva Company Information Table 92. Ceva Business Overview Table 93. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 95. Ceva Recent Development Table 96. Chengdu TECH-BANK Biological Products Co,.Ltd Company Information Table 97. Chengdu TECH-BANK Biological Products Co,.Ltd Business Overview Table 98. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 100. Chengdu TECH-BANK Biological Products Co,.Ltd Recent Development Table 101. ringpu Company Information Table 102. ringpu Business Overview Table 103. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 105. ringpu Recent Development Table 106. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information Table 107. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Business Overview Table 108. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 110. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Development Table 111. DAHUANONG Company Information Table 112. DAHUANONG Business Overview Table 113. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 115. DAHUANONG Recent Development Table 116. CAVAC Company Information Table 117. CAVAC Business Overview Table 118. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 120. CAVAC Recent Development Table 121. Komipharm Company Information Table 122. Komipharm Business Overview Table 123. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 125. Komipharm Recent Development Table 126. Agrovet Company Information Table 127. Agrovet Business Overview Table 128. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 130. Agrovet Recent Development Table 131. Bioveta Company Information Table 132. Bioveta Business Overview Table 133. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 135. Bioveta Recent Development Table 136. JINYU BIO-TECNOLOGY CO.,LTD Company Information Table 137. JINYU BIO-TECNOLOGY CO.,LTD Business Overview Table 138. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 140. JINYU BIO-TECNOLOGY CO.,LTD Recent Development Table 141. Phibro Animal Health Company Information Table 142. Phibro Animal Health Business Overview Table 143. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 144. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 145. Phibro Animal Health Recent Development Table 146. ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information Table 147. ANHUI TIANKANG(GROUP)SHRES O., LTD Business Overview Table 148. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 149. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 150. ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Development Table 151. Zoetis Company Information Table 152. Zoetis Business Overview Table 153. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 154. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 155. Zoetis Recent Development Table 156. WINSUN BIO Company Information Table 157. WINSUN BIO Business Overview Table 158. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 159. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 160. WINSUN BIO Recent Development Table 161. PULIKE BIOLOGICAL ENGINERING,INC. Company Information Table 162. PULIKE BIOLOGICAL ENGINERING,INC. Business Overview Table 163. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 164. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio Table 165. PULIKE BIOLOGICAL ENGINERING,INC. Recent Development Table 166. North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 168. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2026) Table 169. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 170. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Country (2027-2032) Table 171. North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 173. North America Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Country (2021-2026) Table 174. North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. North America Swine Reproductive and Respiratory Syndrome Vaccine Market Share Forecast by Country (2027-2032) Table 176. Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 178. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2026) Table 179. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 180. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Country (2027-2032) Table 181. Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 183. Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Country (2021-2026) Table 184. Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 188. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2026) Table 189. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 190. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 193. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Country (2021-2026) Table 194. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Share Forecast by Country (2027-2032) Table 196. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 198. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2026) Table 199. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 200. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Country (2027-2032) Table 201. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 203. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Country (2021-2026) Table 204. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026) & (K Units) Table 208. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021-2026) Table 209. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 210. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 213. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Country (2021-2026) Table 214. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Share Forecast by Country (2027-2032) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Swine Reproductive and Respiratory Syndrome Vaccine Distributors List Table 219. Swine Reproductive and Respiratory Syndrome Vaccine Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Swine Reproductive and Respiratory Syndrome Vaccine Image Figure 2. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (2021-2032) & (K Units) Figure 5. Active Vaccine Image Figure 6. Global Active Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Inactivated Vaccines Image Figure 8. Global Inactivated Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Swine Reproductive and Respiratory Syndrome Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Government Tender Image Figure 24. Global Government Tender Sales YoY Growth (2021-2032) & (K Units) Figure 25. Market Sales Image Figure 26. Global Market Sales Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Swine Reproductive and Respiratory Syndrome Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Swine Reproductive and Respiratory Syndrome Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Active Vaccine
  • Inactivated Vaccines
Applications
  • Government Tender
  • Market Sales
Companies covered
  • ASCENT CORPORATION
  • Boehringer-Ingelheim
  • MSD Animal Health
  • SPAH
  • Ceva
  • Chengdu TECH-BANK Biological Products Co,.Ltd
  • ringpu
  • QILU ANIMAL HEALTH PRODUCTS CO.,LTD
  • DAHUANONG
  • CAVAC
  • Komipharm
  • Agrovet
  • Bioveta
  • JINYU BIO-TECNOLOGY CO.,LTD
  • Phibro Animal Health
  • ANHUI TIANKANG(GROUP)SHRES O., LTD
  • Zoetis
  • WINSUN BIO
  • PULIKE BIOLOGICAL ENGINERING,INC.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Swine Reproductive and Respiratory Syndrome Vaccine Market by Type
  6. 1.3.1 Active Vaccine
  7. 1.3.2 Inactivated Vaccines
  8. 1.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Type
  9. 1.4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends
  2. 2.2 Swine Reproductive and Respiratory Syndrome Vaccine Industry Drivers
  3. 2.3 Swine Reproductive and Respiratory Syndrome Vaccine Industry Opportunities and Challenges
  4. 2.4 Swine Reproductive and Respiratory Syndrome Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Swine Reproductive and Respiratory Syndrome Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Swine Reproductive and Respiratory Syndrome Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Swine Reproductive and Respiratory Syndrome Vaccine Price (2021-2026)
  4. 3.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Swine Reproductive and Respiratory Syndrome Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Swine Reproductive and Respiratory Syndrome Vaccine Company, Product Type & Application
  7. 3.7 Global Swine Reproductive and Respiratory Syndrome Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Swine Reproductive and Respiratory Syndrome Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Swine Reproductive and Respiratory Syndrome Vaccine Tier 1, Tier 2, and Tier 3
4 Swine Reproductive and Respiratory Syndrome Vaccine Regional Status and Outlook
  1. 4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Historic Market Size by Region
  3. 4.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Swine Reproductive and Respiratory Syndrome Vaccine by Application
  1. 5.1 Swine Reproductive and Respiratory Syndrome Vaccine Market by Application
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Application
  5. 5.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ASCENT CORPORATION
  2. 6.1.1 ASCENT CORPORATION Company Information
  3. 6.1.2 ASCENT CORPORATION Business Overview
  4. 6.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  6. 6.1.5 ASCENT CORPORATION Recent Developments
  7. 6.2 Boehringer-Ingelheim
  8. 6.2.1 Boehringer-Ingelheim Company Information
  9. 6.2.2 Boehringer-Ingelheim Business Overview
  10. 6.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  12. 6.2.5 Boehringer-Ingelheim Recent Developments
  13. 6.3 MSD Animal Health
  14. 6.3.1 MSD Animal Health Company Information
  15. 6.3.2 MSD Animal Health Business Overview
  16. 6.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  18. 6.3.5 MSD Animal Health Recent Developments
  19. 6.4 SPAH
  20. 6.4.1 SPAH Company Information
  21. 6.4.2 SPAH Business Overview
  22. 6.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  24. 6.4.5 SPAH Recent Developments
  25. 6.5 Ceva
  26. 6.5.1 Ceva Company Information
  27. 6.5.2 Ceva Business Overview
  28. 6.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  30. 6.5.5 Ceva Recent Developments
  31. 6.6 Chengdu TECH-BANK Biological Products Co,.Ltd
  32. 6.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
  33. 6.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Business Overview
  34. 6.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  36. 6.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments
  37. 6.7 ringpu
  38. 6.7.1 ringpu Company Information
  39. 6.7.2 ringpu Business Overview
  40. 6.7.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  42. 6.7.5 ringpu Recent Developments
  43. 6.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
  44. 6.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
  45. 6.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Business Overview
  46. 6.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  48. 6.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments
  49. 6.9 DAHUANONG
  50. 6.9.1 DAHUANONG Company Information
  51. 6.9.2 DAHUANONG Business Overview
  52. 6.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  54. 6.9.5 DAHUANONG Recent Developments
  55. 6.10 CAVAC
  56. 6.10.1 CAVAC Company Information
  57. 6.10.2 CAVAC Business Overview
  58. 6.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  60. 6.10.5 CAVAC Recent Developments
  61. 6.11 Komipharm
  62. 6.11.1 Komipharm Company Information
  63. 6.11.2 Komipharm Business Overview
  64. 6.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  66. 6.11.5 Komipharm Recent Developments
  67. 6.12 Agrovet
  68. 6.12.1 Agrovet Company Information
  69. 6.12.2 Agrovet Business Overview
  70. 6.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  72. 6.12.5 Agrovet Recent Developments
  73. 6.13 Bioveta
  74. 6.13.1 Bioveta Company Information
  75. 6.13.2 Bioveta Business Overview
  76. 6.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  78. 6.13.5 Bioveta Recent Developments
  79. 6.14 JINYU BIO-TECNOLOGY CO.,LTD
  80. 6.14.1 JINYU BIO-TECNOLOGY CO.,LTD Company Information
  81. 6.14.2 JINYU BIO-TECNOLOGY CO.,LTD Business Overview
  82. 6.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  84. 6.14.5 JINYU BIO-TECNOLOGY CO.,LTD Recent Developments
  85. 6.15 Phibro Animal Health
  86. 6.15.1 Phibro Animal Health Company Information
  87. 6.15.2 Phibro Animal Health Business Overview
  88. 6.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  90. 6.15.5 Phibro Animal Health Recent Developments
  91. 6.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
  92. 6.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
  93. 6.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Business Overview
  94. 6.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  96. 6.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments
  97. 6.17 Zoetis
  98. 6.17.1 Zoetis Company Information
  99. 6.17.2 Zoetis Business Overview
  100. 6.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  102. 6.17.5 Zoetis Recent Developments
  103. 6.18 WINSUN BIO
  104. 6.18.1 WINSUN BIO Company Information
  105. 6.18.2 WINSUN BIO Business Overview
  106. 6.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  108. 6.18.5 WINSUN BIO Recent Developments
  109. 6.19 PULIKE BIOLOGICAL ENGINERING,INC.
  110. 6.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Company Information
  111. 6.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Business Overview
  112. 6.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
  114. 6.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments
7 North America by Country
  1. 7.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
  2. 7.1.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
  6. 7.2.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
  2. 8.1.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
  6. 8.2.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
  2. 10.1.1 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
  6. 10.2.1 South America Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Swine Reproductive and Respiratory Syndrome Vaccine Value Chain Analysis
  2. 12.1.1 Swine Reproductive and Respiratory Syndrome Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Swine Reproductive and Respiratory Syndrome Vaccine Production Mode & Process
  7. 12.2 Swine Reproductive and Respiratory Syndrome Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors
  10. 12.2.3 Swine Reproductive and Respiratory Syndrome Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst